RR
If you are going to quote from my post, have the common decency to quote accurately.
Firstly the market penetration rate and price point assumptions I used clearly said: "conservative".
By applying a ludicrous 15% assumption for "profit margin" when even the most conservative COGS for Cvac is around 50%, you lose any credibility in your modelling. As for a PER of 10, (for a bio-med it's typically 15-30), the less said the better.
We all know there will be a requirement for additional funds to bring Cvac to market. That's a given. If the trial results of Cvac along the way are positive, there are a raft of opportunities to raise the capital, not withstanding PRR has an untapped debt facility as a fallback option.
Check any number of companies in early stages of development and you'll find it does not require them to post a maiden profit for their market cap to multiply on the expectation of forward earnings. Thats why PER is a forward looking metric.
But then, you're really not interested in any of this stuff, now are you?
- Forums
- ASX - By Stock
- IMM
- i am not impressed
i am not impressed, page-5
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M |
Open | High | Low | Value | Volume |
36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 133736 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.355 |
2 | 9500 | 0.350 |
4 | 199315 | 0.345 |
10 | 84868 | 0.340 |
2 | 10985 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 96182 | 4 |
0.365 | 81517 | 4 |
0.370 | 150545 | 8 |
0.375 | 156434 | 4 |
0.380 | 167642 | 11 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |